These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 928498)

  • 1. Portal venous infusion of paracetamol and antipyrine in the rat.
    Kelleher J; McLachlan MS; Walker BE; Dixon MF; Losowsky MS
    Pharmacol Res Commun; 1977 Sep; 9(8):701-10. PubMed ID: 928498
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diethyl ether anaesthesia on the pharmacokinetics of antipyrine and paracetamol in the rat.
    Johannessen W; Gadeholt G; Aarbakke J
    J Pharm Pharmacol; 1981 Jun; 33(6):365-8. PubMed ID: 6115008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological half-life of phenacetin and phenazone in man before and after treatment with phenobarbital].
    Kampffmeyer HG
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):367-8. PubMed ID: 4253803
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum antipyrine concentrations determined by micellar electrokinetic capillary chromatography.
    Brunner LJ; DiPiro JT; Feldman S
    J Chromatogr; 1993 Dec; 622(1):98-102. PubMed ID: 8120120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A quick DC method for simultaneous quantitative determination of paracetamol, caffeine, phenobarbital and propyphenazone in plasma].
    Kosmeas N; Clerc JT
    Pharm Acta Helv; 1989; 64(1):2-7. PubMed ID: 2717646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice.
    Siegers CP; Strubelt O; Schütt A
    Pharmacology; 1978; 16(5):273-8. PubMed ID: 643897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of changes in antipyrine pharmacokinetics in halothane and paracetamol induced hepatic necrosis in rats.
    Knights KM; Gourlay GK; Hall P; Cousins MJ
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):199-215. PubMed ID: 6878865
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of antipyrine, warfarin and paracetamol in the brushtail possum.
    Eason CT; Wright GR; Gooneratne R
    J Appl Toxicol; 1999; 19(3):157-61. PubMed ID: 10362265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug exposure in rat dietary studies.
    Jochemsen R; Bazot D; Brillanceau MH; Lupart M
    Xenobiotica; 1993 Oct; 23(10):1145-54. PubMed ID: 8259696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of acetaminophen on antipyrine kinetics in rats.
    Vial T; Sauveur C; Descotes J
    Fundam Clin Pharmacol; 1990; 4(1):79-83. PubMed ID: 2341113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters.
    Potter WZ; Thorgeirsson SS; Jollow DJ; Mitchell JR
    Pharmacology; 1974; 12(3):129-43. PubMed ID: 4445191
    [No Abstract]   [Full Text] [Related]  

  • 17. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M; Krom DP; Breimer DD
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Hepatotoxicity and metabolism of paracetamol in rats and mice.
    Siegers CP; Strubelt O; Schütt A
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R93. PubMed ID: 4276651
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrent bromosulphophthalein and antipyrine administration to assess liver blood flow and hepatic enzymes in rats.
    Kaka JS
    Food Chem Toxicol; 1991 Jun; 29(6):419-23. PubMed ID: 1874471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.